These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 905583)

  • 21. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
    Allan G; Eakins KE; Kulkarni PS; Levi R
    Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-specific antagonism against thromboxane A2 of 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG-626) in contraction of isolated smooth muscles.
    Harada Y; Tanaka K; Katori M
    Prostaglandins; 1979 Jun; 17(6):957-66. PubMed ID: 504697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burimamide is a selective inhibitor of thromboxane-A biosynthesis in human platelet microsomes.
    Allan G; Eakins KE
    Prostaglandins; 1978 Apr; 15(4):659-61. PubMed ID: 674697
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB; Leĭtin VL; Repin VS
    Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 27. U-46619, a selective thromboxane A2-like agonist? [proceedings].
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1980 Jan; 68(1):127P-128P. PubMed ID: 7357146
    [No Abstract]   [Full Text] [Related]  

  • 28. Roles of thromboxanes in gastrointestinal physiopathology.
    Bennett TA
    Int J Tissue React; 1983; 5(3):237-9. PubMed ID: 6686219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
    Bunting S; Moncada S; Vane JR
    Br Med Bull; 1983 Jul; 39(3):271-6. PubMed ID: 6354352
    [No Abstract]   [Full Text] [Related]  

  • 30. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S; Ho WK; Ishida U
    J Pharmacol Exp Ther; 1980 Nov; 215(2):357-62. PubMed ID: 7441499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin potentiates synthesis of thromboxane A2 in human platelets.
    Anderson WH; Mohammad SF; Chuang HY; Mason RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():287-91. PubMed ID: 7386269
    [No Abstract]   [Full Text] [Related]  

  • 32. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH; Nichols R; Schmeling JW; Ramwell PW
    Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
    [No Abstract]   [Full Text] [Related]  

  • 33. Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1977; 14(6):1043-53. PubMed ID: 601247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
    Moncada S; Gryglewski R; Bunting S; Vane JR
    Nature; 1976 Oct; 263(5579):663-5. PubMed ID: 802670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
    Aksoy MO; Harakal C; Smith JB; Stewart GJ; Zerweck CR
    Br J Pharmacol; 1990 Mar; 99(3):461-6. PubMed ID: 2110015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Moncada S; Vane JR
    Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
    Eakins KE; Kulkarni PS
    Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboxane a2: biosynthesis and effects on platelets.
    Granström E; Diczfalusy U; Hamberg M; Hansson G; Malmsten C; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():15-58. PubMed ID: 6216781
    [No Abstract]   [Full Text] [Related]  

  • 39. Thromboxane A2 augments adrenergic neurotransmission.
    Stein E; Trachte GJ
    Eicosanoids; 1990; 3(4):205-11. PubMed ID: 1963539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exaggerated prostaglandin and thromboxane synthesis in the renal vein constricted rabbit.
    Myers S; Zipser R; Needleman P
    Adv Prostaglandin Thromboxane Res; 1980; 7():1171-3. PubMed ID: 7369026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.